phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Dementia risk similar with SGLT2 inhibitors and dulaglutide

A nation-wide, population-based cohort study compared the effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors versus dulaglutide on risk for dementia in older patients with type 2 diabetes (T2D).

August 26, 2024


August 29 2024

August 28 2024

August 27 2024

August 26 2024

August 25 2024

August 24 2024

August 23 2024

August 22 2024

August 21 2024

August 20 2024

August 19 2024

August 18 2024

August 17 2024

August 16 2024

August 15 2024

Angell Street Psychiatry
Copyright 2024 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy